PHARMA TWO B
Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. They focus on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505b2 approach). The company develops products in two therapeutic areas with great unmet needs - Parkinson's disease (PD) and Cancer.
PHARMA TWO B
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2007-01-01
Address:
Rehovot, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.pharma2b.com
Total Employee:
1+
Status:
Active
Contact:
972 8 947 2672
Total Funding:
38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Investors List
JK&B Capital
JK&B Capital investment in Series C - Pharma Two B
JVC
JVC investment in Series C - Pharma Two B
Generali Financial Holding
Generali Financial Holding investment in Series C - Pharma Two B
Israel Biotech Fund
Israel Biotech Fund investment in Series C - Pharma Two B
JK&B Capital
JK&B Capital investment in Series B - Pharma Two B
Michael Mittelman
Michael Mittelman investment in Series B - Pharma Two B
Official Site Inspections
http://www.pharma2b.com Semrush global rank: 9.53 M Semrush visits lastest month: 141
- Host name: 167.99.197.46
- IP address: 167.99.197.46
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Pharma Two B"
Pharma Two B - Crunchbase Company Profile & Funding
Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. They focus on Fixed-Dose-combinations of two or more …See details»
Pharma Two B - PitchBook
Jan 12, 2012 Pharma Two B General Information Description. Pharma Two B Ltd is a late clinical-stage pharmaceutical company focused on developing …See details»
Pharma Two B | LinkedIn
Pharma Two B | 561 followers on LinkedIn. Clinical stage pharma company striving to improve patients quality of life by developing innovative combination products | Pharma Two B is a …See details»
Pharma Two B Announces Plans to Go Public via Merger with …
Pharma Two B Ltd. (“Pharma Two B”) has entered into a merger agreement with Hepion Pharmaceuticals, Inc. (“Hepion”) (Nasdaq: HEPA)Immediately upon completion of the merger, …See details»
Pharma Two B - Israeli Startup | Startup Nation Finder
Dec 15, 2021 Pharma Two B is a clinical-stage pharmaceutical company that is developing differentiated and value-added products based on previously approved drugs. The ...See details»
Pharma Two B - VentureRadar
"Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. The company focuses on Fixed-Dose-combinations of two or more drugs with …See details»
Pharma Two B - Craft
Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. We focus on Combination Products of two or more drugs with complementary and …See details»
Pharma Two B - Overview, News & Similar companies - ZoomInfo
Apr 23, 2023 Pharma Two B contact info: Phone number: +972 89472672 Website: www.pharma2b.com What does Pharma Two B do? harma Two B is a clinical-stage …See details»
Pharma Two B - Products, Competitors, Financials, Employees ...
Pharma2b.com. Overview & Products; Financials; People; Founded Year 2008. Stage Series C | Alive. Total Raised $38M. Last Raised $30M | 8 yrs ago. About Pharma Two B. Pharma Two …See details»
Pharma Two B Ltd. - Drug pipelines, Patents, Clinical trials - Patsnap
You may obtain free copies of these documents as described in the preceding paragraph. Contact: Pharma Two BDan TelemanCEOPharma Two B Ltd.Cell: + 972-54-550-0804Email: …See details»
Pharma Two B Ltd. (Pharma Two B Ltd.) - 药物管线_专利_临床试 …
You may obtain free copies of these documents as described in the preceding paragraph. Contact: Pharma Two BDan TelemanCEOPharma Two B Ltd.Cell: + 972-54-550-0804Email: …See details»
Pharma Two B Appoints Jeffrey Berkowitz as Chairman of its Board …
Pharma Two B is led by highly experienced team, supported by prominent scientific and clinical key opinion leaders, and backed by a dedicated group of investors. For more information, …See details»
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing …
Pharma Two B’s lead product candidate is P2B001. For more information, please visit: www.pharma2b.com. About P2B001. P2B001 is an investigational, novel, fixed-dose, …See details»
Pharma Two B Appoints David S. Tierney, M.D. as the Company’s …
Rehovot, Israel – February 18, 2020 – Pharma Two B Ltd., a privately held company developing innovative therapeutics based on previously approved drugs for Parkinson disease, …See details»
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing …
KIRYAT ONO, ISRAEL and EDISON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an …See details»
Press Release – Pharma Two B - pharma2b.com
July 22, 2024 by Pharma2b Pharma Two B Ltd. (“Pharma Two B”) has entered into a merger agreement with Hepion Pharmaceuticals, Inc. (“Hepion”) (Nasdaq: HEPA) Immediately upon …See details»
Pharma Two B Announces Poster Presentation on P2B001 at the …
Dec 5, 2024 Pharma Two B Ltd. Pooled data analysis of efficacy and safety from Phase 2b and Phase 3 data sets in patients with early-stage Parkinson’s disease (PD) support P2B001 as a …See details»
Pharma Two B Announces Poster Presentation on P2B001 at the
May 12, 2024 For over three decades, the PSG Annual Meeting has showcased the organization’s efforts in collaborative research and a commitment to education and …See details»
Pharma Two B Announces Plans to Go Public via Merger with …
Pharma Two B’s lead product is P2B001. For more information, please visit: www.pharma2b.com. About P2B001. P2B001 is an investigational, novel, fixed-dose, extended-release combination …See details»
Pharma Two B Announces Positive Topline Results from its Pivotal …
Company plans to file an NDA in 2022. REHOVOT, Israel , Dec. 15, 2021 (GLOBE NEWSWIRE) -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based on …See details»